Onglyza (on-GLY-zah), the second "gliptin" for type 2 diabetes

Reps will be promoting Onglyza (on-GLY-zah), the second "gliptin" for type 2 diabetes....

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote